Illumina (ILMN) Other Non-Current Liabilities (2010 - 2026)
Illumina (ILMN) posted quarterly Other Non-Current Liabilities of $289.0 million for Q2 2026, down 16.95% year-over-year from $348.0 million in Q2 2025, and down 17.9% on a QoQ basis from $352.0 million in Q1 2026.
Illumina (ILMN) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Illumina has reported Other Non-Current Liabilities for 17 years, with the latest figure at $289.0 million in Q2 2026.
- Other Non-Current Liabilities for Q2 2026 came in at $289.0 million, down 16.95% year-over-year; the trailing twelve-month figure through Jun 2026 was $289.0 million (down 16.95% YoY), and the FY2025 annual result was $360.0 million, up 6.19% from the prior year.
- Other Non-Current Liabilities eased to $289.0 million in Q2 2026, from $352.0 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $915.0 million in Q1 2022 and troughed at $289.0 million in Q2 2026.
- A 5-year average of $529.4 million and a median of $555.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The widest annual swing landed in 2022, when Other Non-Current Liabilities surged 5992.86%; it then sank 52.85% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $613.0 million in 2022, then gained by 1.14% to $620.0 million in 2023, then plunged by 45.32% to $339.0 million in 2024, then increased by 6.19% to $360.0 million in 2025, then declined by 19.72% to $289.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $289.0 million in Q2 2026, $352.0 million in Q1 2026, and $360.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 289.00 Mn |
| Mar 29, 2026 | 352.00 Mn |
| Dec 28, 2025 | 360.00 Mn |
| Sep 28, 2025 | 334.00 Mn |
| Jun 29, 2025 | 348.00 Mn |
| Mar 30, 2025 | 344.00 Mn |
| Dec 29, 2024 | 339.00 Mn |
| Sep 29, 2024 | 313.00 Mn |
| Jun 30, 2024 | 331.00 Mn |
| Mar 31, 2024 | 642.00 Mn |
| Dec 31, 2023 | 620.00 Mn |
| Oct 1, 2023 | 555.00 Mn |
| Jul 2, 2023 | 702.00 Mn |
| Apr 2, 2023 | 654.00 Mn |
| Jan 1, 2023 | 649.00 Mn |
| Oct 2, 2022 | 613.00 Mn |
| Jul 3, 2022 | 853.00 Mn |
| Apr 3, 2022 | 845.00 Mn |
| Jan 2, 2022 | 915.00 Mn |
| Oct 3, 2021 | 1.09 Bn |